Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Fair Value, Assets Measured on Nonrecurring Basis

At March 31, 2018 and December 31, 2017, intangible assets were measured at fair value on a nonrecurring basis as shown in the following tables.

 

    Quoted Price in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs
(Level 3)
    Balance at
March 31, 2018
    Impairment Loss  
Patents and other technologies   $     $     $ 1,501,367     $ 1,501,367     $  
                                         

 

    Quoted Price in Active Markets for Identical Assets
(Level 1)
    Significant Other Observable Inputs
(Level 2)
    Significant Unobservable Inputs
(Level 3)
    Balance at December 31, 2017     Impairment Loss  
Patents and other technologies   $     $     $ 1,583,260     $ 1,583,260     $ 923,769  
Goodwill                             397,569  
Total   $     $     $ 1,583,260     $ 1,583,260     $ 1,321,338  

 

Schedule of cash balances by geographic area

At March 31, 2018 and December 31, 2017, the Company’s cash balances by geographic area were as follows:

 

Country:   March 31, 2018     December 31, 2017  
United States   $ 873,663       41.1 %   $ 1,700,024       56.2 %
China     1,251,993       58.9 %     1,327,009       43.8 %
Total cash   $ 2,125,656       100.0 %   $ 3,027,033       100.0 %
Schedule of reconciliation of basic and diluted net income (loss) per share

The following table presents a reconciliation of basic and diluted net loss per share:

 

    Three Months Ended March 31, 2018     Three Months Ended March 31, 2017  
Net loss available to Avalon GloboCare Corp. for basic and diluted net loss per share of common stock   $ (1,481,579 )   $ (549,333 )
Weighted average common stock outstanding - basic and diluted     69,781,733       62,595,289  
Net loss per common share attributable to Avalon GloboCare Corp. - basic and diluted   $ (0.02 )   $ (0.01 )